1. Home
  2. TTAN vs RGEN Comparison

TTAN vs RGEN Comparison

Compare TTAN & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TTAN
  • RGEN
  • Stock Information
  • Founded
  • TTAN 2012
  • RGEN 1981
  • Country
  • TTAN United States
  • RGEN United States
  • Employees
  • TTAN N/A
  • RGEN N/A
  • Industry
  • TTAN
  • RGEN Medical/Dental Instruments
  • Sector
  • TTAN
  • RGEN Health Care
  • Exchange
  • TTAN NYSE
  • RGEN Nasdaq
  • Market Cap
  • TTAN 8.4B
  • RGEN 7.1B
  • IPO Year
  • TTAN 2024
  • RGEN N/A
  • Fundamental
  • Price
  • TTAN $119.89
  • RGEN $130.00
  • Analyst Decision
  • TTAN Buy
  • RGEN Buy
  • Analyst Count
  • TTAN 14
  • RGEN 12
  • Target Price
  • TTAN $115.54
  • RGEN $175.56
  • AVG Volume (30 Days)
  • TTAN 544.3K
  • RGEN 951.5K
  • Earning Date
  • TTAN 03-13-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • TTAN N/A
  • RGEN N/A
  • EPS Growth
  • TTAN N/A
  • RGEN N/A
  • EPS
  • TTAN N/A
  • RGEN N/A
  • Revenue
  • TTAN $771,878,000.00
  • RGEN $634,439,000.00
  • Revenue This Year
  • TTAN $19.04
  • RGEN $12.29
  • Revenue Next Year
  • TTAN $13.40
  • RGEN $15.20
  • P/E Ratio
  • TTAN N/A
  • RGEN N/A
  • Revenue Growth
  • TTAN 25.64
  • RGEN 0.33
  • 52 Week Low
  • TTAN $79.81
  • RGEN $102.97
  • 52 Week High
  • TTAN $123.48
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • TTAN N/A
  • RGEN 48.60
  • Support Level
  • TTAN N/A
  • RGEN $105.06
  • Resistance Level
  • TTAN N/A
  • RGEN $135.81
  • Average True Range (ATR)
  • TTAN 0.00
  • RGEN 9.95
  • MACD
  • TTAN 0.00
  • RGEN 1.83
  • Stochastic Oscillator
  • TTAN 0.00
  • RGEN 82.31

About TTAN SERVICETITAN INC

ServiceTitan Inc is an end-to-end technology platform built for contractors to transform the performance of their businesses. The Company's platform provides business owners, technicians, customer service representatives and other key office staff with technology tools designed to help customers grow revenue, drive operational efficiencies, deliver a superior end-customer experience and monitor key business drivers in real-time.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: